Achieving success when treating young patients with breast cancer (ID 1822)
Treatment paradigm in the era of CDK 4/6 inhibitors - What's New in 2019 ? (ID 1823)
PI3K inhibitors in advanced breast cancer: What has changed? (ID 1824)
Panel discussion (ID 1825)